查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1718235

阿片类药物市场：2025-2030 年全球预测（按鸦片类药物类型、给药方式、用途和最终用户）

Opioids Market by Opioid Types, Mode of Administration, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

鸦片类药物市场预计到 2024 年将达到 108.8 亿美元，到 2025 年将达到 114.4 亿美元，到 2030 年将达到 147.9 亿美元，复合年增长率为 5.24%。

主要市场统计数据
基准年2024年 108.8亿美元
预计2025年 114.4亿美元
预测年份 2030 147.9亿美元
复合年增长率（%） 5.24%

阿片类药物市场正处于不断变化的患者需求、监管改革和先进研发的十字路口。该分析探讨了市场的当前和未来前景，并强调了将继续影响其发展轨蹟的关键因素。过去几年，临床实践和治疗通讯协定的细微变化使得我们必须彻底审查供需动态。市场参与企业，包括医疗保健提供者和政策法规，被要求在有效疼痛管理的迫切需求和病人安全的更广泛要求之间取得平衡。数据主导的决策越来越多地指南治疗、护理和风险管理的创新。这次全面的回顾检验了科学进步与经济因素之间的相互作用，为理解复杂的市场状况奠定了基础。与循证策略一致的投资对于帮助产业应对复杂的社会、监管和技术挑战至关重要。这项市场概览为深入探究变革性变化、细分洞察以及区域和公司特定动态奠定了基础，以揭示阿片类药物市场的整体情况。

重新定义阿片类药物市场的变革性转变

市场最近的转型变化正在重新定义相关人员对鸦片类药物的看法和互动方式。法律规范的快速变化和对以患者为中心的护理的重新关注导致了重大的调整。传统分销管道正在透过技术整合进行最佳化，以便在保持严格安全通讯协定的同时快速获得高品质的配方。此外，新的研究正在推动模式转移，从广泛使用鸦片类药物转向更有针对性的治疗方法。这种演变凸显了能够快速响应临床指南和患者人口统计数据变化的适应性经营模式的重要性。同时，产业创新也不断缩小治疗效果与风险管理之间的差距。经济压力和竞争正在推动研究机构和製药公司之间的合作，巩固精准和个人化医疗将占据主导地位的未来。这种调整不仅仅是被动的，而且是对长期存在的市场挑战的主动回应。加强科学研究、改善病患监测通讯协定和数位医疗解决方案的整合将提高市场效率，确保治疗方法进步惠及患者，同时加强合规性和道德规范。

全面的细分洞察塑造市场分析

对市场的详细研究揭示了可以从多方面细分框架中获得的见解。在考虑鸦片类药物的类型时，市场分析师会区分天然鸦片类药物、半合成鸦片类药物和合成鸦片类药物。在天然鸦片类药物中，我们透过研究可待因和氢可酮增加了进一步的细微差别。另一方面，我们对半合成鸦片类药物的分析重点是氢可酮和羟可酮。快速发展的合成鸦片类药物具有不同的子类别，例如Fentanyl和美沙酮。分析不仅限于化学分类，还涉及给药方式，其中口服给药（包括胶囊和锭剂）发挥重要作用，此外还有肌肉注射和静脉注射等经皮途径，以及越来越多地采用的透皮给药方式。按应用细分进一步细分不同的临床部分，例如麻醉（分为全身麻醉和局部麻醉）以及急性和慢性疼痛管理。最后，最终用户分析探讨了诊所和医院、居家医疗和研究机构等医疗保健设施的细微差别。这种多方面的细分提供了详细的视图，对于策略决策和业务规划都很有帮助。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 慢性和急性疼痛疾病盛行率上升导致阿片类药物消费量增加
      • 扩大医疗保健基础设施和服务，以改善阿片类药物治疗的可近性
      • 扩大药物研发将有助于推出新的鸦片类药物。
    • 限制因素
      • 阿片类药物处方管理高成本
    • 机会
      • 扩大远端医疗服务，为医疗服务匮乏的地区提供鸦片类药物成瘾咨询和治疗
      • 开发行动应用程式以支持阿片类药物成瘾康復并与社区建立联繫
    • 任务
      • 严格管理阿片类药物的处方和分发
  • 市场区隔分析
    • 鸦片类药物类型：有效缓解疼痛导致天然鸦片类药物的采用率增加
    • 应用：增加阿片类药物在疼痛管理的应用，以治疗急性和慢性疼痛
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 阿片类药物市场（依鸦片类药物类型）

  • 天然鸦片类药物
    • 可待因
    • 氢可酮
  • 半合成鸦片类药物
    • 氢可酮
    • 羟可酮
  • 合成鸦片类药物
    • Fentanyl
    • 美沙酮

7. 阿片类药物市场（依给药方式）

  • 口服途径
    • 胶囊
    • 药片
  • 肠外给药
    • 肌肉注射
    • 静脉
  • 经经皮给药

8. 阿片类药物市场（依应用）

  • 麻醉
    • 全身麻醉
    • 局部麻醉
  • 止咳药
  • 疼痛管理
    • 急性疼痛
    • 慢性疼痛

9. 阿片类药物市场（依最终用户划分）

  • 医疗保健设施
    • 诊所
    • 医院
  • 家庭医疗保健
  • 研究机构

第十章美洲鸦片类药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

11. 亚太地区阿片类药物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

12. 欧洲、中东和非洲阿片类药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Abbott Laboratories
  • AbbVie Inc.
  • Accord Healthcare, Ltd.
  • Alkermes plc
  • AmerisourceBergen Corporation
  • Bristol Laboratories Limited
  • Johnson Matthey Plc
  • Mallinckrodt LLC
  • Noramco, Inc.
  • Omnica Laboratories
  • Purdue Pharma LP
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
Product Code: MRR-CB04E05659AC

The Opioids Market was valued at USD 10.88 billion in 2024 and is projected to grow to USD 11.44 billion in 2025, with a CAGR of 5.24%, reaching USD 14.79 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 10.88 billion
Estimated Year [2025] USD 11.44 billion
Forecast Year [2030] USD 14.79 billion
CAGR (%) 5.24%

The opioids market stands at a crossroads of evolving patient needs, regulatory reform, and advanced research and development. In this analysis, we explore the market's current state and future potential, highlighting the pivotal factors that continue to shape its trajectory. Over the past few years, nuances in clinical practices and treatment protocols have necessitated a thorough reexamination of both supply and demand dynamics. Market participants, including healthcare providers and policy regulators, are being urged to balance the critical need for effective pain management with the broader imperative of patient safety. Increasingly, data-driven decisions are guiding innovations in therapy, treatment delivery, and risk management. This comprehensive review lays the groundwork for understanding the market's intricate landscape, examining the interplay between scientific progress and economic factors. As the industry navigates complex social, regulatory, and technical challenges, it is essential to align investment with evidenced-based strategies. This overview sets the stage for a deeper dive into transformative shifts, segmentation insights, and regional and company-specific dynamics that provide a holistic picture of the opioids market.

Transformative Shifts Redefining the Opioids Market

Recent transformative shifts in the market have redefined how stakeholders perceive and engage with opioids. Rapid changes in regulatory frameworks and a renewed focus on patient-centric care have led to significant realignments. Traditional distribution channels are being optimized through technological integration, enabling faster access to high-quality formulations while maintaining stringent safety protocols. Emerging research is driving a paradigm shift from broad-spectrum opioid applications to more targeted treatment regimens. This evolution underscores the importance of adaptive business models that can swiftly respond to changing clinical guidelines and patient demographics. In parallel, industry innovation continues to bridge the gap between therapeutic efficacy and risk management. Economic pressures and competitive forces are fostering collaborations between research institutions and pharmaceutical companies, cementing a future where precision therapies and personalized medicine dominate. Such adaptive measures are not simply reactive; they are proactive responses to long-standing market challenges. The convergence of enhanced scientific research, improved patient monitoring protocols, and digital healthcare solutions has amplified market efficiency, ensuring that therapeutic advances reach the patient while reinforcing compliance and ethical practices.

Comprehensive Segmentation Insights Shaping Market Analysis

A detailed examination of the market reveals insights that stem from a multi-faceted segmentation framework. When considering opioid types, the market analysis distinguishes among natural opiates, semi-synthetic opioids, and synthetic opioids. The natural opiates category is further nuanced by its study of codeine and morphine, whereas semi-synthetic opioids are dissected with a focus on hydrocodone and oxycodone. Synthetic opioids, a rapidly evolving segment, are characterized by distinct subcategories such as fentanyl and methadone. Beyond the chemical classification, the analysis extends to modes of administration, where oral delivery including capsules and tablets plays a significant role alongside parenteral routes like intramuscular and intravenous methods, and the increasingly adopted transdermal approaches. Application-based segmentation further elaborates distinct clinical segments such as anesthesia, which is methodically divided into general and regional anesthesia, and pain management, which addresses both acute and chronic conditions. Finally, an end-user analysis investigates the nuances among healthcare facilities, noted for their dual focus on clinics and hospitals, home healthcare, and research institutes. This multifaceted segmentation provides a granular view that informs both strategic decision-making and operational planning.

Based on Opioid Types, market is studied across Natural Opiates, Semi-Synthetic Opioids, and Synthetic Opioids. The Natural Opiates is further studied across Codeine and Morphine. The Semi-Synthetic Opioids is further studied across Hydrocodone and Oxycodone. The Synthetic Opioids is further studied across Fentanyl and Methadone.

Based on Mode of Administration, market is studied across Oral Administration, Parenteral Administration, and Transdermal Administration. The Oral Administration is further studied across Capsules and Tablets. The Parenteral Administration is further studied across Intramuscular and Intravenous.

Based on Application, market is studied across Anesthesia, Cough Suppression, and Pain Management. The Anesthesia is further studied across General Anesthesia and Regional Anesthesia. The Pain Management is further studied across Acute Pain and Chronic Pain.

Based on End-User, market is studied across Healthcare Facilities, Home Healthcare, and Research Institutes. The Healthcare Facilities is further studied across Clinics and Hospitals.

Key Regional Dynamics Influencing Market Growth

The opioids market exhibits distinct regional characteristics driven by varied economic, regulatory, and healthcare factors. In the Americas, the market is influenced by robust healthcare systems and evolving policies that emphasize patient safety and innovation. Concurrently, regions spanning Europe, the Middle East, and Africa experience a blend of stringent regulatory oversight coupled with dynamic market opportunities, as diverse healthcare systems adapt to emerging treatment protocols. Meanwhile, Asia-Pacific stands out with its rapidly expanding pharmaceutical industries, heightened research capabilities, and significant investments in healthcare infrastructure. These regions collectively demonstrate unique growth trajectories, challenges, and opportunities that influence market behavior at both a macro and micro level. The interplay among these regions highlights the need for localized strategies that account for cultural, economic, and regulatory differences. As countries balance modernization with legacy systems, investors and key stakeholders are provided with a rich tapestry of market insights that underscore the importance of both global collaboration and regional specialization in achieving competitive advantage.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Companies Driving Innovation in the Opioids Market

The competitive landscape in the opioids market is marked by the strategic initiatives of several key industry leaders. Major players such as Abbott Laboratories and AbbVie Inc. are continuously refining their research and development processes to pioneer advanced therapeutic solutions. Companies like Accord Healthcare, Ltd. and Alkermes plc have initiated strategic collaborations to enhance both drug efficacy and safety profiles. Globally recognized entities, including AmerisourceBergen Corporation and Bristol Laboratories Limited, contribute to market dynamism by streamlining supply chains and adopting innovative distribution models. This landscape is further enriched by the initiatives of Johnson Matthey Plc, Mallinckrodt LLC, and Noramco, Inc., which are instrumental in translating research breakthroughs into marketable solutions. Omnica Laboratories, Purdue Pharma L.P., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. round out the competitive narrative by emphasizing quality, compliance, and next-generation innovations. Through continuous investment in technology and research, these companies are shaping the future of the industry, undertaking rigorous measures to balance market growth with patient-centered care and global safety standards.

The report delves into recent significant developments in the Opioids Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Accord Healthcare, Ltd., Alkermes plc, AmerisourceBergen Corporation, Bristol Laboratories Limited, Johnson Matthey Plc, Mallinckrodt LLC, Noramco, Inc., Omnica Laboratories, Purdue Pharma L.P., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Actionable Recommendations for Industry Leaders

Industry leaders are encouraged to adopt a proactive stance in navigating the complexities of the opioids market. It is imperative to invest in research and development initiatives that promote the creation of safer and more effective opioid formulations. Companies should focus on strengthening their quality assurance measures and expanding their portfolio through strategic partnerships and acquisitions. Embracing digital transformation can further streamline production, distribution, and patient monitoring processes, ensuring that innovations are rapidly integrated into clinical practice. In addition, fostering open collaboration with regulatory bodies will facilitate smoother market entry and sustained growth. It is also recommended that decision-makers prioritize market education and transparent communication strategies to build trust among stakeholders. These strategic interventions should be paired with robust risk management practices to mitigate potential liabilities. Emphasizing continuous improvement through feedback loops from clinical outcomes and market performance will empower companies to adapt in real time, ensuring they remain competitive in a swiftly evolving marketplace.

Conclusion and Forward-Looking Perspectives

In conclusion, the analysis of the opioids market provides a deep and insightful perspective into a sector that is critical to modern healthcare. The evolving dynamics, driven by both external regulatory pressures and internal innovation, are crafting a future that prioritizes patient safety, quality care, and scientific advancement. By dissecting the market through detailed segmentation and regional analysis, this review underscores the importance of a balanced approach that integrates clinical expertise with market intelligence. The competitive landscape, shaped by leading industry players, further highlights the necessity for agile strategies in the face of emerging challenges. As the market continues to evolve, stakeholders are urged to maintain a forward-looking perspective that embraces change and leverages data-driven insights for sustainable growth. This comprehensive review offers not just a summary of current trends, but a roadmap for navigating future opportunities in a complex and vital market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic and acute pain conditions drives up opioid medication consumption
      • 5.1.1.2. Expansion of healthcare infrastructure and services enhancing accessibility to opioid treatments
      • 5.1.1.3. Expanding pharmaceutical research and development contributes to the introduction of new opioids
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with opioid prescription management
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding telehealth services for opioid addiction counseling and treatment in underserved areas
      • 5.1.3.2. Developing mobile apps for opioid addiction recovery support and community connectivity
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations to control the prescription and distribution of opioids
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Opioid Types: Rising adoption of natural opiates due to their effective pain-relieving properties
    • 5.2.2. Application: Rising application of opioids in pain management to manage both acute and chronic pain conditions
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Opioids Market, by Opioid Types

  • 6.1. Introduction
  • 6.2. Natural Opiates
    • 6.2.1. Codeine
    • 6.2.2. Morphine
  • 6.3. Semi-Synthetic Opioids
    • 6.3.1. Hydrocodone
    • 6.3.2. Oxycodone
  • 6.4. Synthetic Opioids
    • 6.4.1. Fentanyl
    • 6.4.2. Methadone

7. Opioids Market, by Mode of Administration

  • 7.1. Introduction
  • 7.2. Oral Administration
    • 7.2.1. Capsules
    • 7.2.2. Tablets
  • 7.3. Parenteral Administration
    • 7.3.1. Intramuscular
    • 7.3.2. Intravenous
  • 7.4. Transdermal Administration

8. Opioids Market, by Application

  • 8.1. Introduction
  • 8.2. Anesthesia
    • 8.2.1. General Anesthesia
    • 8.2.2. Regional Anesthesia
  • 8.3. Cough Suppression
  • 8.4. Pain Management
    • 8.4.1. Acute Pain
    • 8.4.2. Chronic Pain

9. Opioids Market, by End-User

  • 9.1. Introduction
  • 9.2. Healthcare Facilities
    • 9.2.1. Clinics
    • 9.2.2. Hospitals
  • 9.3. Home Healthcare
  • 9.4. Research Institutes

10. Americas Opioids Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Opioids Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Opioids Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. ANANDA Scientific announces a clinical trial evaluating Nantheia ATL5, in the treatment of co-occurring Opioid Use
    • 13.3.2. FDA approval of over-the-counter naloxone nasal spray by Amneal set to transform opioid overdose intervention accessibility
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AbbVie Inc.
  • 3. Accord Healthcare, Ltd.
  • 4. Alkermes plc
  • 5. AmerisourceBergen Corporation
  • 6. Bristol Laboratories Limited
  • 7. Johnson Matthey Plc
  • 8. Mallinckrodt LLC
  • 9. Noramco, Inc.
  • 10. Omnica Laboratories
  • 11. Purdue Pharma L.P.
  • 12. Sun Pharmaceutical Industries Ltd.
  • 13. Teva Pharmaceutical Industries Ltd.
  • 14. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. OPIOIDS MARKET MULTI-CURRENCY
  • FIGURE 2. OPIOIDS MARKET MULTI-LANGUAGE
  • FIGURE 3. OPIOIDS MARKET RESEARCH PROCESS
  • FIGURE 4. OPIOIDS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL OPIOIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL OPIOIDS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL OPIOIDS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL OPIOIDS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL OPIOIDS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL OPIOIDS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES OPIOIDS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES OPIOIDS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. OPIOIDS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. OPIOIDS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. OPIOIDS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL OPIOIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OPIOIDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OPIOIDS MARKET DYNAMICS
  • TABLE 7. GLOBAL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OPIOIDS MARKET SIZE, BY CODEINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OPIOIDS MARKET SIZE, BY MORPHINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL OPIOIDS MARKET SIZE, BY HYDROCODONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL OPIOIDS MARKET SIZE, BY OXYCODONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL OPIOIDS MARKET SIZE, BY FENTANYL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL OPIOIDS MARKET SIZE, BY METHADONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL OPIOIDS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL OPIOIDS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL OPIOIDS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL OPIOIDS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL OPIOIDS MARKET SIZE, BY TRANSDERMAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL OPIOIDS MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL OPIOIDS MARKET SIZE, BY GENERAL ANESTHESIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL OPIOIDS MARKET SIZE, BY REGIONAL ANESTHESIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL OPIOIDS MARKET SIZE, BY COUGH SUPPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL OPIOIDS MARKET SIZE, BY ACUTE PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL OPIOIDS MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL OPIOIDS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL OPIOIDS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL OPIOIDS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL OPIOIDS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. CANADA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 100. MEXICO OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. MEXICO OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. MEXICO OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. MEXICO OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. MEXICO OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED STATES OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED STATES OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED STATES OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. UNITED STATES OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. UNITED STATES OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 117. UNITED STATES OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. UNITED STATES OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 120. UNITED STATES OPIOIDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 134. AUSTRALIA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 136. AUSTRALIA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 138. AUSTRALIA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. AUSTRALIA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. AUSTRALIA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 144. AUSTRALIA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 146. CHINA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 147. CHINA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 148. CHINA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 149. CHINA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 150. CHINA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. CHINA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 152. CHINA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 153. CHINA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. CHINA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 155. CHINA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 156. CHINA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. CHINA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 158. INDIA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 159. INDIA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 160. INDIA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 161. INDIA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 162. INDIA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 163. INDIA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. INDIA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 165. INDIA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. INDIA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 167. INDIA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 168. INDIA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. INDIA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 170. INDONESIA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 171. INDONESIA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 172. INDONESIA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 173. INDONESIA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 174. INDONESIA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 175. INDONESIA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. INDONESIA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. INDONESIA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. INDONESIA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 179. INDONESIA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 180. INDONESIA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. INDONESIA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 182. JAPAN OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 183. JAPAN OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 184. JAPAN OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 185. JAPAN OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 186. JAPAN OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 187. JAPAN OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 188. JAPAN OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 189. JAPAN OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. JAPAN OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 191. JAPAN OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 192. JAPAN OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. JAPAN OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 194. MALAYSIA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 195. MALAYSIA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 196. MALAYSIA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 197. MALAYSIA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 198. MALAYSIA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 199. MALAYSIA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 200. MALAYSIA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 201. MALAYSIA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. MALAYSIA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 203. MALAYSIA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 204. MALAYSIA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. MALAYSIA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 206. PHILIPPINES OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 207. PHILIPPINES OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 208. PHILIPPINES OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 209. PHILIPPINES OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 210. PHILIPPINES OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 211. PHILIPPINES OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 212. PHILIPPINES OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. PHILIPPINES OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 216. PHILIPPINES OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 218. SINGAPORE OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 219. SINGAPORE OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 220. SINGAPORE OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 221. SINGAPORE OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 222. SINGAPORE OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 223. SINGAPORE OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 224. SINGAPORE OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 225. SINGAPORE OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. SINGAPORE OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 227. SINGAPORE OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 228. SINGAPORE OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. SINGAPORE OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 230. SOUTH KOREA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 231. SOUTH KOREA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 232. SOUTH KOREA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 233. SOUTH KOREA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 234. SOUTH KOREA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH KOREA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH KOREA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH KOREA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH KOREA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH KOREA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 242. TAIWAN OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 243. TAIWAN OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 244. TAIWAN OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 245. TAIWAN OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 246. TAIWAN OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 247. TAIWAN OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 248. TAIWAN OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 249. TAIWAN OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. TAIWAN OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 251. TAIWAN OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 252. TAIWAN OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. TAIWAN OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 254. THAILAND OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 255. THAILAND OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 256. THAILAND OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 257. THAILAND OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 258. THAILAND OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 259. THAILAND OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 260. THAILAND OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 261. THAILAND OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. THAILAND OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 263. THAILAND OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 264. THAILAND OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. THAILAND OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 266. VIETNAM OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 267. VIETNAM OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 268. VIETNAM OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 269. VIETNAM OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 270. VIETNAM OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 271. VIETNAM OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 272. VIETNAM OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 273. VIETNAM OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. VIETNAM OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 275. VIETNAM OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 276. VIETNAM OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 277. VIETNAM OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 291. DENMARK OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 292. DENMARK OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 293. DENMARK OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 294. DENMARK OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 295. DENMARK OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 296. DENMARK OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 297. DENMARK OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 298. DENMARK OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 299. DENMARK OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 300. DENMARK OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 301. DENMARK OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 302. DENMARK OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 303. EGYPT OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 304. EGYPT OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 305. EGYPT OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 306. EGYPT OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 307. EGYPT OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 308. EGYPT OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 309. EGYPT OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 310. EGYPT OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 311. EGYPT OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 312. EGYPT OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 313. EGYPT OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 314. EGYPT OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 315. FINLAND OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 316. FINLAND OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 317. FINLAND OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 318. FINLAND OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 319. FINLAND OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 320. FINLAND OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 321. FINLAND OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 322. FINLAND OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 323. FINLAND OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 324. FINLAND OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 325. FINLAND OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 326. FINLAND OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 327. FRANCE OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 328. FRANCE OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 329. FRANCE OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 330. FRANCE OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 331. FRANCE OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 332. FRANCE OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 333. FRANCE OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 334. FRANCE OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 335. FRANCE OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 336. FRANCE OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 337. FRANCE OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 338. FRANCE OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 339. GERMANY OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 340. GERMANY OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 341. GERMANY OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 342. GERMANY OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 343. GERMANY OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 344. GERMANY OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 345. GERMANY OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 346. GERMANY OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 347. GERMANY OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 348. GERMANY OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 349. GERMANY OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 350. GERMANY OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 351. ISRAEL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 352. ISRAEL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 353. ISRAEL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 354. ISRAEL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 355. ISRAEL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 356. ISRAEL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 357. ISRAEL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 358. ISRAEL OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 359. ISRAEL OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 360. ISRAEL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 361. ISRAEL OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 362. ISRAEL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 363. ITALY OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 364. ITALY OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 365. ITALY OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 366. ITALY OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 367. ITALY OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 368. ITALY OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 369. ITALY OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 370. ITALY OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 371. ITALY OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
  • TABLE 372. ITALY OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 373. ITALY OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 374. ITALY OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
  • TABLE 375. NETHERLANDS OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
  • TABLE 376. NETHERLANDS OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
  • TABLE 377. NETHERLANDS OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 378. NETHERLANDS OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
  • TABLE 379. NETHERLANDS OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 380. NETHERLANDS O